(Q67862000)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1792931%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

title

Moclobemide in depression: a randomized, multicentre trial against isocarboxazide and clomipramine emphasizing atypical depression (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1792931%20AND%20SRC:MED&resulttype=core&format=json

multicenter clinical trial

18 September 2019

main subject

1 reference

1 reference

J. K. Larsen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1792931

27 November 2022

A. Gjerris

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1792931

27 November 2022

P. Holm

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1792931

27 November 2022

J. Anderson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1792931

27 November 2022

A. Bille

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1792931

27 November 2022

E. M. Christensen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1792931

27 November 2022

E. Høyer

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1792931

27 November 2022

H. Jensen

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1792931

27 November 2022

A. Mejlhede

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1792931

27 November 2022

A. Langagergaard

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1792931

27 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1792931

27 November 2022

publication date

1 December 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1792931%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

18 September 2019

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1600-0447.1991.tb03196.x

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03196.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0447.1991.tb03196.x/fullpdf

27 November 2022

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03196.X

Acta Psychiatrica Scandinavica

27 November 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1792931%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

volume

84

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1792931%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1792931%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

page(s)

564-570

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1792931%20AND%20SRC:MED&resulttype=core&format=json

Moclobemide and clomipramine in the treatment of depression. A randomized clinical trial

18 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03196.X

A Placebo-controlled Study of the Antidepressant Activity of Moclobemide,A New MAO-A Inhibitor

27 November 2022

2

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03196.X

A controlled study of a specific MAO A reversible inhibitor (R011-1163) and amitriptyline in depressive illness

27 November 2022

4

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03196.X

Moclobemide and clomipramine in endogenous depression. A randomized clinical trial

27 November 2022

6

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03196.X

Journal of neural transmission

27 November 2022

8

28

45

Laux G.

1989

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03196.X

A clinical overview of monoamine oxidase inhibitors

27 November 2022

9

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03196.X

The present status of monoamine oxidase inhibitors

27 November 2022

10

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03196.X

Phenelzine v imipramine in atypical depression. A preliminary report

27 November 2022

11

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03196.X

Antidepressant specificity in atypical depression.

27 November 2022

12

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03196.X

A rating scale for depression

27 November 2022

13

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03196.X

The assessment of anxiety states by rating

27 November 2022

15

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03196.X

The Hamilton Anxiety Scale. Evaluation of homogeneity and inter-observer reliability in patients with depressive disorders

27 November 2022

16

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03196.X

An efficacy study of isocarboxazid and placebo in depression, and its relationship to depressive nosology.

27 November 2022

19

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03196.X

Moclobemide and clomipramine in reactive depression. A placebo-controlled randomized clinical trial

27 November 2022

24

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03196.X

Treatment strategy in depression. II. MAO inhibitors in depression resistant to cyclic antidepressants: two controlled crossover studies with tranylcypromine versus L-5-hydroxytryptophan and nomifensine

27 November 2022

26

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03196.X

Journal of neural transmission

27 November 2022

27

26

123

Rafaelsen OJ.

1988

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03196.X

Anxiety state or masked depression? A study based on the action of monoamine oxidase inhibitors.

27 November 2022

28

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03196.X

Isocarboxazid. Efficacy and tolerance.

27 November 2022

30

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03196.X

Response to phenelzine and amitriptyline in subtypes of outpatient depression.

27 November 2022

31

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03196.X

Responses to phenelzine and amitriptyline absence of differential predictors by multiple regression analysis

27 November 2022

32

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03196.X

Atypical depression, panic attacks, and response to imipramine and phenelzine. A replication

27 November 2022

33

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03196.X

Response to phenelzine and imipramine in placebo nonresponders with atypical depression. A new application of the crossover design

27 November 2022

34

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03196.X

CSF-adrenaline--low in "somatizing depression".

27 November 2022

35

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03196.X

27 November 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1792931%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

1 reference